Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: Involvement of nuclear factorκB and Ets transcription factors

Molecular Endocrinology

Volumn 16, Issue 8, 2002, Pages 1752-1766

  Eberhardt, Wolfgang ^a   Schulze, Maja ^a   Engels, Christina ^a   Klasmeier, Elke ^a   Pfeilschifter, Josef ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; GELATINASE B; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MIFEPRISTONE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1; DNA; ETS1 PROTEIN, RAT; INTERLEUKIN 1; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME REPRESSION; GLOMERULOSCLEROSIS; HORMONE RESPONSIVE ELEMENT; MESANGIUM CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; RAT; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; ZYMOGRAPHY; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; MESANGIUM; METABOLISM; MOLECULAR GENETICS;

ANIMAL; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; CLONING, MOLECULAR; DEXAMETHASONE; DNA; GELATINASE B; GENE EXPRESSION; GLOMERULAR MESANGIUM; GLUCOCORTICOIDS, SYNTHETIC; I-KAPPA B; INTERLEUKIN-1; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RATS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; ANIMALS; GLUCOCORTICOIDS; I-KAPPA B PROTEINS; MATRIX METALLOPROTEINASE 9; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTOR RELA;

ANIMALIA;

EID: 0036020493     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2001-0278     Document Type: Article

References (41)

1. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
2. Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor
3. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
4. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
5. Transcriptional cross-talk, the second mode of steroid hormone receptor action
6. Matrix metalloproteinases
7. Proteinases and glomerular matrix turnover
8. Role of oxidants and proteases in glomerular injury
9. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
10. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines
11. Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1
12. The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription
13. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells
14. Amplification of IL-1β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-κB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways
15. The Ets family of transcription factors
16. Spatial flexibility in ternary complexes between SRF and its accessory proteins
17. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression
18. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters
19. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated drokinase and collagenase genes in response to epidermal growth factor
20. Over-expression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: Effects of steroid and immunosuppressive treatment
21. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during skin wound repair
22. Therapeutic strategies for the inhibition id inducible nitric oxide synthase: Potential for a novel class of anti-inflammatry agents
23. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium
24. Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells
25. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects
26. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells
27. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: Variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical giucocorticoids
28. Cross-talk between glucocorticoid receptor and AP-1
29. Tumor necrosis factor-α activation of NF-κB requires the phosphoryiation of Ser-471 in the transactivation domain of c-Rel
30. NF-κB controls expression of inhibitor IκBα: Evidence for an inducible autoregulatory pathway
31. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: Evidence for the involvement of transcriptional and posttranscriptional regulation
32. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites
33. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins
34. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
35. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells
36. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors
37. Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the cytochrome P-450c27 promoter
38. Participation of Ets transcription factors in the glucocorticoid response of the rat tyrosine aminotransferase gene
39. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1β and cAMP in rat mesangial cells
40. Potentiation of nitric oxide synthase expression by superoxide in interleukin 1β-stimulated rat mesangial cells
41. Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT): Implications for early wound healing